...
首页> 外文期刊>BMC Infectious Diseases >No polymorphisms in K13-propeller gene associated with artemisinin resistance in Plasmodium falciparum isolated from Brazzaville, Republic of Congo
【24h】

No polymorphisms in K13-propeller gene associated with artemisinin resistance in Plasmodium falciparum isolated from Brazzaville, Republic of Congo

机译:与刚果洲巴拉维尔群中的疟原虫抗性抗蒿属植物抗性相关的K13-螺旋桨基因中没有多态性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

In the Republic of Congo, artemisinin-based combinations have been recommended for the treatment of uncomplicated malaria since 2006. However, the emergence of resistant parasites again these combinations in Southeast Asia is a threat for the control of this disease, especially in sub-Saharan Africa where the weight of the disease is important. Indeed, polymorphisms in Plasmodium falciparum K13-propeller gene have been involved in variations of drug sensitivity of Plasmodium falciparum to artemisinin-based combinations. The aim of the current study is to determine the prevalence of mutations of this gene in isolates collected in three health centers in Brazzaville. From May 2015 to May 2016, a total of 131, 259 and 416 samples from patients with suspected malaria were collected at the Laboratoire National de Santé Publique, H?pital de Mfilou, and the CSI ?Maman Mboualé? respectively. After DNA isolation, genotyping and sequencing of Plasmodium falciparum K13-propeller were performed in positive Plasmodium falciparum isolates identified after msp-2 gene genotyping. All 806 samples collected were msp-2 genotyped and Plasmodium falciparum infections were confirmed in 287 samples with 43, 85, 159 samples from Laboratoire National de Santé Publique, H?pital de Mfilou, and the CSI ?Maman Mboualé? respectively. Of these 287 msp-2 positives samples, K13-propeller nested PCR products were successfully obtained from 145 (50.52%) isolates and sequences were generated from 127(87.58%) nested products. None of mutations that were associated with ACTs resistance in Southeast Asia were detected on the samples from three different study sites from Brazzaville. However, one mutation type was observed at position 578, where alanine was substituted by serine (A578S) in two isolates (1.57%, 2/127), those from the H?pital de Mfilou. No mutation was found in isolates from the two other sites. The current study shows a very limited polymorphism in the K13-propeller gene in isolates from the Republic of Congo and K13 polymorphisms associate with ACT resistance are not present in this country. However, permanent and large surveillance of resistant parasite population using K13-propeller gene is recommended.
机译:在刚果共和国,自2006年以来,已建议蒿属植物的组合用于治疗简单的疟疾。然而,抗性寄生虫再次在东南亚的组合是对这种疾病的控制,特别是在撒哈拉州的威胁非洲疾病的重量很重要。实际上,疟原虫K13-螺旋桨基因中的多态性已经参与了疟原虫对青蒿素基组合的疟原虫敏感性的变化。目前研究的目的是确定Brazzaville三个保健中心收集的分离物中该基因突变的患病率。从2015年5月到2016年5月,在Laboratoire National deSantéPublique,HajordeMfilou和CSI的患者中收集了来自疑似疟疾患者的131,259和416个样本,以及CSI?MamanMboualé?分别。在DNA分离后,在MSP-2基因基因分型后鉴定的阳性疟原虫分离物中进行疟原虫K13-螺旋桨的基因分型和测序。收集的所有806个样本是MSP-2基因分型和疟原虫感染,在287个样品中确认了43,85,85,159个样本,来自Laboratoire National deSantéPublique,H?Pital de Mfilou和CSI?MamanMboualé?分别。在这些287个MSP-2阳性样品中,从145(50.52%)分离物中成功获得K13螺旋桨嵌套PCR产物,序列由127(87.58%)嵌套产品产生。没有与东南亚作用抗性相关的突变被检测到从布拉柴维尔的三种不同研究地点的样本上检测到。然而,在第578位观察一个突变类型,其中丙氨酸被丝氨酸(A578S)取代,其中两种分离株(1.57%,2/127),来自H的那些.Pital de Mfilou。在两个其他网站的分离物中没有发现突变。目前的研究表明,在刚果共和国的分离株中,K13-Propeller基因中的一种非常有限的多态性,K13多态性在这个国家不存在与作用抵抗的助理。然而,建议使用K13-螺旋桨基因永久性和大的抗性寄生虫群。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号